|
|
DSpace at RU >
Browsing by Author Putte, L.B.A. van de
Showing results 36 to 55 of 72
| Full Text | Issue Date | Title | Author(s) | | 1998 | Imaging of inflamed joints in patients with active rheumatoid arthritis with radiolabeled interleukin-1 receptor antagonist. Initial results | Laken, C.J. van der; Barrera, P.; Boerman, O.C., et al |
| 1995 | Inclusion body myositis responding to longterm chlorambucil treatment | Jongen, P.J.H.; Laak, H.J. ter; Putte, L.B.A. van de |
| 1995 | Indices of disease activity in rheumatoid arthritis | Riel, P.L.C.M. van; Prevoo, M.L.L.; Gestel, A.M. van, et al |
| 1997 | Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis: towards development of a decision support system | Leeuwen, M.A. van; Rijswijk, M.H. van; Sluiter, W.J., et al |
| 1995 | Infections during low-dose methotrexate treatment in rheumatoid arthritis | Boerbooms, A.M.T.; Kerstens, P.J.S.M.; Loenhout, J.W.A. van, et al |
| 1995 | Infections during low-dose methotrexate treatment in rheumatoid arthritis | Boerbooms, A.M.T.; Kerstens, P.J.S.M.; Loenhout, J.W.A. van, et al |
| 1994 | Interference of circulating azathioprine but not methotrexate or sulfasalazine with measurements of interleukin-6 bioactivity | Barrera, P.; Boerbooms, A.M.Th.; Sauerwein, R.W., et al |
| 2011 | The interferon regulatory factor 5 gene confers susceptibility to rheumatoid arthritis and influences its erosive phenotype | Dawidowicz, K.; Allanore, Y.; Guedj, M., et al |
| 2006 | Intranasal administration of recombinant human cartilage glycoprotein-39. A phase I escalating cohort study in patients with rheumatoid arthritis. | Zandbelt, M.; Houbiers, J.G.A.; Hoogen, F.H.J. van den, et al |
| 2007 | The ITGAV rs3738919-C allele is associated with rheumatoid arthritis in the European Caucasian population: a family-based study. | Jacq, L.; Garnier, S.; Dieude, P., et al |
| 2007 | Linkage proof for PTPN22, a rheumatoid arthritis susceptibility gene and a human autoimmunity gene. | Michou, L.; Lasbleiz, S.; Rat, A.C., et al |
| 1995 | Long-term usage and side-effect profile of sulphasalazine in rheumatoid arthritis | Riel, P.L.C.M. van; Gestel, A.M. van; Putte, L.B.A. van de |
| 1996 | Major infections during methotrexate treatment for rheumatoid arthritis | Boerbooms, A.M.T.; Kerstens, P.J.S.M.; Loephout, J.W.A. van, et al |
| 1995 | Methods of Scoring Radiographic Changes in Rheumatoid-Arthritis | Putte, L.B.A. van de |
| 1995 | Methotrexate in severe ankylosing spondylitis: an open study | Creemers, M.C.W.; Franssen, M.J.A.M.; Putte, L.B.A. van de, et al |
| 1995 | Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis | Prevoo, M.L.L.; Hof, M.A. van 't; Kuper, H.H., et al |
| 1997 | Monocytes/macrophages rather than PMN are involved in early cartilage degradation in cationic immune complex arthritis in mice | Lent, P.L.E.M. van; Blom, A.B.; Holthuysen, A.E.M., et al |
| 1997 | Mycobacterium xenopi artritis and spondylodiscitis | Telgt, D.S.C.; Hoogen, F.H.J. van den; Meis, J.F.G.M., et al |
| 1996 | New perspectives on controlling progression of severe rheumatoid arthritis - a summary of the potential role of cyclosporin | Emery, P.; Putte, L.B.A. van de |
| 1995 | Oral steroids as bridge therapy in rheumatoid arthritis patients starting with parenteral gold: a randomized double-blind placebo-controlled trial | Gestel, A.M. van; Laan, R.F.J.M.; Haagsma, C.J., et al |
Showing results 36 to 55 of 72
|